Seeking broad, durable protection, Pfizer and BioNTech move T-cell enhancing COVID vaccine into clinic With the walls closing in for Clovis, FDA demands ovarian cancer restriction for Rubraca Humana's CenterWell aiming to open at least 30 new clinics next year Insulet's power problems grow with FDA battery recall, Omnipod 5 charger notice GSK severs Immatics partnership in T-cell retreat that claimed Lyell last month Takeda's Iclusig delivers a win in rare subtype of acute lymphoblastic leukemia Editas shelves lead asset after proof-of-concept data whittles down likely patient population | 